In one study including 6 CML patients, plasma levels of beta-TG and PF4 were not reduced and platelet aggregation did not improve following normalization of leukocyte and platelet counts after busulfan or hydroxyurea [7]. The gene discussed is PF4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.